A composition for enhancing libido of a pharmaceutically effective amount of a libido-enhancing therapeutic of (5S,10R,13S,17S)-13-methyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17yl acetate (Formula I), (3S,5S,10R,13S,17S)-3-hydroxy-13-methylhexadecahydro-1H-cyclopenta[a]phenanthren-17yl acetate (Formula II), (5S,10S,13S,17S)-17-hydroxy-13-methyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one (Formula III), isomers thereof, analogs thereof, or combinations thereof, and a pharmaceutically acceptable carrier. A method of enhancing libido, by administering the composition to an individual in need of an enhanced libido, and enhancing libido in the individual or animal which is male or female. A method of enhancing libido, by administering the composition of the present invention to an individual at an age when libido and sexual desire have naturally decreased, and enhancing libido in the individual. A composition for enhancing libido and arousal, including a pharmaceutically effective amount of a libido-enhancing therapeutic in combination with a sexual dysfunction therapeutic. A method of enhancing libido and arousal.Linvention concerne : une composition permettant daugmenter la libido constituée dune quantité pharmaceutiquement efficace dun agent thérapeutique augmentant la libido dacétate de (5S,10R,13S,17S)-13-méthyl-3-oxohexadécahydro-1H-cyclopenta[a]phénanthrén-17yle (formule I), dacétate de (3S,5S,10R,13S,17S)-3-hydroxy-13-méthylhexadécahydro-1H-cyclopenta[a]phénanthrén-17yle (formule II), de (5S,10S,13S,17S)-17-hydroxy-13-méthyltétradécahydro-1H-cyclopenta[a]phénanthrén-3(2H)-one (formule III), des isomères associés, des analogues associés, ou de combinaisons associées, et dun transporteur pharmaceutiquement acceptable une méthode permettant daugmenter la libido, en administrant la composition à un individu qui a besoin dune libido accrue, et en augmentant la libido chez lindividu ou lanimal qui est un mâle ou une femelle une méthode permettant daug
